22/07/2024
🚀 Big news! Endless Health, a leader in at-home testing and preventive medicine, just secured $4.5M in Series Seed funding! The round was led by Next Coast Ventures, which was an early investor in Everly Health, Asset Management Ventures, and Antler Elevate.
We’re developing the first fully at-home clinical trial services, including self-home collection kits, central lab services, and more. This means accurate, affordable, and accessible testing for thousands of Americans, tracking crucial blood markers for longevity. Endless Health will conclude its first clinical trials later this summer for at-home and point of care medical devices that promote longevity.
Co-founder and CEO Cooper Galvin, PhD, shares, “These funds will allow us to scale up our white-label testing services to millions of people. We are leveraging those at-home testing capabilities to launch clinical trials at a fraction of the cost and time. We can now expand our panels from at-home blood tests for cardiovascular disease risk to linked conditions such as Alzheimer’s disease. The future of healthcare is preventive medicine”
Jiabao Li, Chief Design Officer and co-founder, emphasized the importance of the funds for product innovation: “These funds will allow us to enhance our product design and build the first plug-and-play at-home clinical trial and prevention programs. The challenge we are taking on is to make clinical trials and prevention programs easy to plan, fun to execute and participate in, retain participants and researchers, and more informative to the real-world performance of devices or therapeutics.
Endless Health is on a mission to bring preventive healthcare to every home, making a real difference in tackling heart disease and other chronic conditions. Stay tuned as we continue to innovate and expand!
Learn more by visiting http://besthearttest.com
